Delivering gene-editing tools to mice while they were still developing in the womb corrected the mutated CFTR gene that causes…
Margarida Maia, PhD
Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Maia, PhD
Adding the experimental treatment CMTX-101 to standard antibiotics reduced the number of Pseudomonas aeruginosa — a type of bacteria…
While most adults with cystic fibrosis (CF) view their health as very good or excellent while on Kalydeco…
Using inhaled antibiotics can help control the growth of certain bacteria in the lungs, but it may increase the risk of fungal…
In young children with cystic fibrosis (CF), infections with methicillin-resistant Staphylococcus aureus (MRSA) are linked to more antibiotic use,…
Home-based spirometry — a test to measure how well the lungs are working — provides results that are almost as…
Regular exercise improves fitness in adults with cystic fibrosis (CF), and treatment with Kaftrio — a combination of elexacaftor,…
People with diabetes related to cystic fibrosis (CF) who had better long-term sugar control were more fit, a study…
Kaftrio (elexacaftor/tezacaftor/ivacaftor), branded as Trikafta in the U.S., may help clear the nasal passages and surrounding air-filled cavities, known…
Pregnancy does not negatively impact survival or lung function in women with cystic fibrosis (CF) and, in fact, may…